Novartis Int'l Reports Nine New Analyses Show Co.'s LCZ696 Could Avert Course of Heart Failure for Patients
November 17, 2014 at 16:47 PM EST
Novartis International AG / Nine new analyses show Novartis' LCZ696 could change course of heart failure for patients[1],[2] . ...